Anthony P Khawaja, Luís Abegão Pinto, Ingeborg Stalmans, Florent Aptel, Anna Barkander, Keith Barton, Henny Beckers, Milko Iliev, Thomas Klink, Giorgio Marchini, Jose Martínez de la Casa, Karin R Pillunat, Jan H Simonsen, Clemens Vass
INTRODUCTION: The PRESERFLO™ MicroShunt (PMS) has been proven to significantly lower intraocular pressure (IOP) in patients with glaucoma and has been available for use since 2019. With increasing published evidence and growing experience of glaucoma surgeons, the aim of this modified Delphi panel was to build on the findings of a previous Delphi panel conducted in 2021 and provide further guidance on the role of the PMS to treat patients with glaucoma in Europe. METHODS: Thirteen European glaucoma surgeons experienced in the PMS procedure participated in a 3-round modified Delphi panel...
April 8, 2024: Ophthalmology and Therapy